RWE Informs Decision-Making for Vaccines, Digital Therapeutics, and Medications

September 16, 2021

Real world evidence (RWE) is increasingly used in healthcare and pharma decision-making. A recent article explores its use in addressing questions related to COVID-19 vaccines, digital therapeutics, and medications. Tracking patient outcomes is critical in understanding the impact of these products and can accompany results from clinical trials.

“RWE helps researchers understand how patient characteristics and behaviors affect health outcomes, which helps to predict the progression of a disease and a patient’s response to a vaccine or therapy…RWE allows real-time analysis and inclusion of specific patient information, which can ultimately provide higher quality care for patients.” Read more here.

(Source: Samantha McGrail, Pharma News Intelligence, 9/10/21)

Share This Story!